- Home
- OPK vs PLSE Comparison
OPK vs PLSE Comparison
Compare OPK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- PLSE
- Stock Information
- Founded
- OPK 2007
- PLSE 2014
- Country
- OPK United States
- PLSE United States
- Employees
- OPK N/A
- PLSE N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- PLSE Medical/Dental Instruments
- Sector
- OPK Health Care
- PLSE Health Care
- Exchange
- OPK Nasdaq
- PLSE Nasdaq
- Market Cap
- OPK 1.0B
- PLSE 1.1B
- IPO Year
- OPK 1995
- PLSE 2016
- Fundamental
- Price
- OPK $1.39
- PLSE $15.52
- Analyst Decision
- OPK Buy
- PLSE Buy
- Analyst Count
- OPK 4
- PLSE 1
- Target Price
- OPK $2.75
- PLSE $22.00
- AVG Volume (30 Days)
- OPK 1.9M
- PLSE 169.1K
- Earning Date
- OPK 11-06-2025
- PLSE 10-29-2025
- Dividend Yield
- OPK N/A
- PLSE N/A
- EPS Growth
- OPK N/A
- PLSE N/A
- EPS
- OPK N/A
- PLSE N/A
- Revenue
- OPK $664,029,000.00
- PLSE N/A
- Revenue This Year
- OPK N/A
- PLSE N/A
- Revenue Next Year
- OPK $0.84
- PLSE $700.00
- P/E Ratio
- OPK N/A
- PLSE N/A
- Revenue Growth
- OPK N/A
- PLSE N/A
- 52 Week Low
- OPK $1.11
- PLSE $13.77
- 52 Week High
- OPK $2.04
- PLSE $25.00
- Technical
- Relative Strength Index (RSI)
- OPK 51.08
- PLSE 52.02
- Support Level
- OPK $1.34
- PLSE $13.83
- Resistance Level
- OPK $1.44
- PLSE $15.21
- Average True Range (ATR)
- OPK 0.04
- PLSE 0.70
- MACD
- OPK -0.00
- PLSE -0.06
- Stochastic Oscillator
- OPK 45.00
- PLSE 55.14
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.